These microbial shifts correlated with reduced pro-inflammatory cytokines (e.g., IL-1β, TNF-α), improved RA clinical and bone parameters, and elevated levels of short-chain fatty acids (SCFAs), particularly butyrate and propionate. The gene discussed is IL1B; the disease is rheumatoid arthritis.